
  
    
      
        Background_NNP
        Bone_NNP morphogenetic_JJ proteins_NNS (_( BMPs_NNP )_) are_VBP secreted_JJ
        signaling_VBG molecules_NNS of_IN the_DT TGF-Î²_NNP superfamily_RB that_WDT have_VBP been_VBN
        implicated_VBN in_IN the_DT control_NN of_IN a_DT host_NN of_IN critical_JJ
        developmental_NN phenomena_NNS in_IN the_DT central_JJ and_CC peripheral_JJ
        nervous_JJ systems_NNS [_NN 1_CD 2_CD 3_CD ]_NN ._. BMP-_NNP 5_CD ,_, one_CD of_IN the_DT more_RBR
        prominently_RB expressed_VBD BMPs_NNP in_IN the_DT nervous_JJ system_NN ,_, has_VBZ been_VBN
        detected_VBN in_IN multiple_JJ regions_NNS of_IN the_DT nervous_JJ system_NN
        throughout_IN development_NN and_CC into_IN adulthood_NN [_NN 3_CD 4_CD 5_CD 6_CD ]_NN ,_, yet_RB
        its_PRP$ biological_JJ activities_NNS in_IN the_DT nervous_JJ system_NN are_VBP not_RB
        well_RB defined_VBN ._. A_DT role_NN for_IN BMP-_NNP 5_CD in_IN dorsal_NN forebrain_NN
        patterning_VBG has_VBZ been_VBN proposed_VBN based_VBN on_IN its_PRP$ expression_NN in_IN the_DT
        dorsal_NN midline_NN of_IN the_DT developing_VBG forebrain_NN and_CC observations_NNS
        that_IN ectopic_JJ expression_NN of_IN BMP-_NNP 5_CD in_IN the_DT developing_VBG neural_NN
        tube_NN of_IN chicks_NNS markedly_RB downregulates_NNS ventral_NN markers_NNS while_IN
        maintaining_VBG dorsal_NN markers_NNS [_NN 5_CD 7_CD ]_NN ._. Further_RB support_NN for_IN
        BMP-_NNP 5_CD regulation_NN of_IN early_JJ forebrain_NN development_NN has_VBZ been_VBN
        provided_VBN by_IN studies_NNS of_IN 
        Bmp_NNP 5_CD /_NN Bmp_NNP 7_CD double_JJ mutants_NNS [_NN 6_CD ]_NN ._.
        However_RB ,_, reports_NNS that_IN BMP-_NNP 5_CD in_IN the_DT mouse_NN brain_NN exhibits_VBZ
        peak_NN expression_NN levels_NNS in_IN the_DT adult_NN striatum_NN and_CC brainstem_NN
        and_CC that_DT maximal_NN expression_NN in_IN the_DT hippocampus_JJ and_CC
        cerebellum_NN occurs_VBZ at_IN E_NNP 18_CD through_IN PN_NNP 1_CD and_CC again_RB in_IN the_DT
        mature_VBP nervous_JJ system_NN [_NN 3_CD ]_NN ,_, suggest_VBP additional_JJ roles_NNS for_IN
        BMP-_NNP 5_CD during_IN later_JJ stages_VBZ of_IN neural_NN development_NN and_CC into_IN
        adulthood_NN ._.
        BMPs_NNP have_VBP been_VBN divided_VBN into_IN subgroups_NNS based_VBN on_IN
        structural_JJ and_CC evolutionary_JJ considerations_NNS [_NN 8_CD ]_NN ._. Although_IN
        closely_RB related_VBN BMPs_NNP have_VBP been_VBN shown_VBN to_TO elicit_NN distinct_JJ
        cellular_JJ responses_NNS [_NN 5_CD 9_CD 10_CD 11_CD 12_CD 13_CD ]_NN ,_, members_NNS within_IN a_DT
        subgroup_NN often_RB display_NN conservation_NN of_IN not_RB only_RB structure_VB ,_,
        but_CC also_RB function_VB [_NN 4_CD 5_CD 6_CD 14_CD ]_NN ._. BMP-_NNP 5_CD belongs_VBZ to_TO the_DT 60_CD A_DT
        subgroup_NN of_IN BMPs_NNP ,_, which_WDT also_RB includes_VBZ BMP-_NNP 6_CD /_NN Vgr-_NNP 1_CD ,_,
        BMP-_NNP 7_CD /_NN OP-_NNP 1_CD ,_, BMP-_NNP 8_CD a_DT /_NN OP-_NNP 2_CD ,_, BMP-_NNP 8_CD b_SYM and_CC Drosophila_NNP 60_CD A_DT [_NN 3_CD 8_CD ]_NN
        ._. Other_JJ members_NNS of_IN the_DT 60_CD A_DT subgroup_NN have_VBP been_VBN shown_VBN to_TO
        modulate_VBP neuronal_NN morphogenesis_NNS through_IN selective_JJ effects_NNS
        on_IN dendrites_NNS ._. Thus_RB ,_, BMPs_NNP 6_CD ,_, 7_CD ,_, and_CC 60_CD A_DT stimulate_VB dendritic_JJ
        growth_NN in_IN cultured_JJ sympathetic_JJ neurons_NNS derived_VBN from_IN either_DT
        perinatal_NN or_CC adult_NN ganglia_NN in_IN the_DT absence_NN of_IN effects_NNS on_IN
        cell_NN survival_NN or_CC axonal_NN growth_NN [_NN 15_CD 16_CD 17_CD ]_NN ._. BMP-_NNP 7_CD has_VBZ
        also_RB been_VBN shown_VBN to_TO enhance_VB dendritic_JJ growth_NN in_IN hippocampal_NN ,_,
        cortical_JJ and_CC spinal_JJ motor_NN neurons_NNS [_NN 18_CD 19_CD 20_CD ]_NN ._.
        Whether_IN BMP-_NNP 5_CD similarly_RB promotes_VBZ dendritic_JJ growth_NN has_VBZ
        not_RB been_VBN previously_RB addressed_VBN ._. Since_IN dendrites_NNS are_VBP the_DT
        primary_JJ site_NN of_IN synapse_NN formation_NN ,_, we_PRP felt_VBD it_PRP was_VBD important_JJ
        to_TO examine_VB this_DT possibility_NN ._. Moreover_RB ,_, since_IN dendritic_JJ
        remodeling_NN occurs_VBZ throughout_IN the_DT life_NN of_IN the_DT animal_NN ,_, such_JJ
        studies_NNS could_MD suggest_VB a_DT function_NN for_IN BMP-_NNP 5_CD in_IN the_DT adult_NN
        nervous_JJ system_NN ._. In_IN this_DT report_NN ,_, we_PRP demonstrate_VBP that_IN like_IN
        other_JJ members_NNS of_IN the_DT 60_CD A_DT subgroup_NN ,_, BMP-_NNP 5_CD triggers_VBZ robust_JJ
        dendritic_JJ growth_NN in_IN sympathetic_JJ neurons_NNS 
        in_IN vitro_NN coincident_JJ with_IN activation_NN
        of_IN Smad-_NNP 1_CD ._. Noggin_NNP and_CC follistatin_NN ,_, soluble_JJ proteins_NNS known_VBN
        to_TO function_VB as_IN physiological_JJ antagonists_NNS for_IN BMP-_NNP 7_CD [_NN 21_CD ]_NN ,_,
        also_RB inhibit_VB the_DT dendrite-promoting_JJ activity_NN of_IN BMP-_NNP 5_CD ._.
        Furthermore_RB ,_, BMP-_NNP 5_CD mRNA_NN and_CC protein_NN are_VBP detected_VBN in_IN intact_JJ
        sympathetic_JJ ganglia_NN and_CC neuron_NN /_NN glia_NN cocultures_NNS ,_,
        respectively_RB ,_, consistent_JJ with_IN a_DT proposed_VBN role_NN for_IN BMP-_NNP 5_CD in_IN
        regulating_VBG dendritic_JJ growth_NN in_IN sympathetic_JJ neurons_NNS 
        in_IN vivo_NN ._. 
      
      
        Results_NNS
        
          BMP-_NNP 5_CD induces_VBZ dendritic_JJ growth_NN in_IN cultured_JJ
          sympathetic_JJ neurons_NNS
          As_IN previously_RB reported_VBD [_NN 16_CD ]_NN ,_, sympathetic_JJ neurons_NNS
          grown_VBN in_IN the_DT absence_NN of_IN serum_NN and_CC glial_NN cells_NNS fail_VBP to_TO
          form_VB dendrites_NNS (_( Figure_NN 1_CD A_DT )_) ;_: however_RB when_WRB grown_VBN in_IN the_DT
          presence_NN of_IN BMP-_NNP 7_CD ,_, these_DT neurons_NNS extend_VBP multiple_JJ
          dendrites_NNS (_( Figure_NN 1_CD B_NNP )_) ._. Similarly_RB ,_, addition_NN of_IN recombinant_JJ
          human_JJ BMP-_NNP 5_CD to_TO the_DT culture_NN medium_NN elicits_NNS dendritic_JJ
          growth_NN in_IN sympathetic_JJ neurons_NNS as_IN evidenced_VBN by_IN the_DT
          presence_NN of_IN tapered_JJ processes_NNS that_WDT are_VBP immunoreactive_JJ for_IN
          MAP_NNP 2_CD (_( Figure_NN 1_CD C_NNP )_) ._. Comparative_NNP analyses_NNS of_IN
          concentration-effect_JJ relationships_NNS for_IN BMP-_NNP 7_CD and_CC BMP-_NNP 5_CD
          (_( Figure_NN 2_LS )_) ,_, indicate_VBP EC_NNP 
          50_CD values_NNS for_IN BMP-_NNP 5_CD approximately_RB
          10_CD -_: fold_VB higher_JJR than_IN those_DT of_IN BMP-_NNP 7_CD ;_: however_RB maximally_RB
          effective_JJ concentrations_NNS of_IN these_DT two_CD growth_NN factors_NNS have_VBP
          comparable_JJ effects_NNS on_IN sympathetic_JJ neurons_NNS as_IN assessed_VBN by_IN
          the_DT percentage_NN of_IN neurons_NNS with_IN dendritic_JJ growth_NN ,_, the_DT
          number_NN of_IN dendrites_NNS per_IN cell_NN ,_, and_CC the_DT total_JJ dendritic_JJ
          length_NN per_IN cell_NN ._. Time_NN course_NN studies_NNS of_IN dendritic_JJ growth_NN
          in_IN neurons_NNS exposed_VBN to_TO maximally_RB effective_JJ concentrations_NNS
          of_IN BMP-_NNP 5_CD and_CC BMP-_NNP 7_CD reveal_VB comparable_JJ temporal_JJ responses_NNS
          as_RB well_RB (_( Figure_NN 3_LS )_) ._. Both_DT BMP-_NNP 5_CD and_CC BMP-_NNP 7_CD elicit_NN dendrite_NN
          formation_NN in_IN 90_CD -_: 100_CD %_NN of_IN the_DT neuronal_NN cell_NN population_NN
          within_IN 24_CD to_TO 48_CD hr_NN (_( Figure_NN 3_CD A_DT )_) ._. The_DT gradual_JJ increase_NN in_IN
          the_DT number_NN of_IN dendrites_NNS per_IN cell_NN throughout_IN a_DT 17_CD -_: day_NN
          treatment_NN with_IN BMP-_NNP 5_CD parallels_NNS that_WDT observed_VBD in_IN sister_NN
          cultures_NNS exposed_VBN to_TO BMP-_NNP 7_CD during_IN the_DT same_JJ period_NN (_( Figure_NN
          3_CD B_NNP )_) ._. Experiments_NNS in_IN which_WDT cultured_JJ sympathetic_JJ neurons_NNS
          were_VBD treated_VBN simultaneously_RB with_IN maximally_RB effective_JJ
          concentrations_NNS of_IN BMP-_NNP 5_CD and_CC BMP-_NNP 7_CD indicate_VBP that_IN the_DT
          effects_NNS of_IN BMP-_NNP 5_CD and_CC BMP-_NNP 7_CD on_IN dendritic_JJ growth_NN are_VBP not_RB
          additive_JJ (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Treatment_NNP of_IN sympathetic_JJ neurons_NNS with_IN BMP-_NNP 5_CD induces_VBZ
          phosphorylation_NN of_IN Smad_NNP 1_CD
          In_IN most_JJS cell_NN systems_NNS that_WDT have_VBP been_VBN examined_VBN ,_, the_DT
          primary_JJ signal_NN transduction_NN pathway_NN for_IN BMPs_NNP involves_VBZ
          phosphorylation_NN of_IN Smad-_NNP 1_CD [_NN 22_CD ]_NN ,_, and_CC recent_JJ evidence_NN
          suggests_VBZ that_IN this_DT is_VBZ also_RB true_JJ for_IN BMP-_NNP 7_CD induced_VBN
          dendritic_JJ growth_NN in_IN sympathetic_JJ neurons_NNS [_NN 23_CD ]_NN ._. To_TO
          determine_VB if_IN BMP-_NNP 5_CD initiates_NNS similar_JJ signaling_VBG events_NNS in_IN
          sympathetic_JJ neurons_NNS ,_, cultured_JJ sympathetic_JJ neurons_NNS grown_VBN
          in_IN the_DT absence_NN of_IN glial_NN cells_NNS were_VBD treated_VBN with_IN BMP-_NNP 5_CD for_IN
          30_CD or_CC 60_CD min_NN then_RB analyzed_VBN by_IN Western_NNP blotting_VBG using_VBG Abs_NNP
          specific_JJ for_IN total_JJ Smad-_NNP 1_CD or_CC for_IN phosphorylated_JJ Smad-_NNP 1_CD ._.
          Phosphorylation_NNP of_IN Smad-_NNP 1_CD is_VBZ evident_JJ within_IN 30_CD min_NN after_IN
          exposure_NN to_TO BMP-_NNP 5_CD (_( Figure_NN 4_CD A_DT )_) with_IN significantly_RB
          increased_VBN pSmad-_NN 1_CD levels_NNS apparent_JJ at_IN 60_CD min_NN ._. In_IN contrast_NN ,_,
          treatment_NN with_IN BMP-_NNP 5_CD did_VBD not_RB alter_VB levels_NNS of_IN total_JJ Smad-_NNP 1_CD
          (_( Figure_NN 4_CD B_NNP )_) ._.
        
        
          Antagonists_NNP of_IN BMP-_NNP function_NN inhibit_VB BMP-_NNP 5_CD -_: induced_VBN
          dendritic_JJ growth_NN
          Recent_JJ data_NNS suggest_VBP that_IN in_IN the_DT developing_VBG nervous_JJ
          system_NN ,_, signaling_VBG by_IN at_IN least_JJS BMPs_NNP 2_CD ,_, 4_CD and_CC 7_CD is_VBZ
          determined_VBN by_IN the_DT spatiotemporal_NN expression_NN patterns_NNS of_IN
          BMPs_NNP and_CC their_PRP$ receptors_NNS ,_, and_CC by_IN relative_JJ levels_NNS of_IN the_DT
          soluble_JJ BMP_NN antagonists_NNS such_JJ as_IN follistatin_NN and_CC noggin_NN
          that_IN directly_RB bind_NN BMPs_NNP in_IN the_DT extracellular_NN compartment_NN
          and_CC prevent_VB functional_JJ receptor_NN /_NN ligand_NN interaction_NN [_NN 1_CD 24_CD
          25_CD 26_CD 27_CD 28_CD ]_NN ._. The_DT extent_NN to_TO which_WDT these_DT factors_NNS may_MD
          regulate_VB BMP-_NNP 5_CD signaling_VBG is_VBZ difficult_JJ to_TO determine_VB
          because_IN of_IN the_DT paucity_NN of_IN data_NNS regarding_VBG either_CC
          antagonism_NN of_IN BMP-_NNP 5_CD signaling_VBG by_IN follistatin_NN and_CC noggin_NN
          or_CC the_DT interaction_NN between_IN known_VBN BMP_NN receptors_NNS and_CC BMP-_NNP 5_CD ._.
          To_TO address_VB the_DT former_JJ question_NN ,_, we_PRP tested_VBD the_DT ability_NN of_IN
          follistatin_NN and_CC noggin_NN to_TO block_VB the_DT dendrite-promoting_JJ
          activity_NN of_IN BMP-_NNP 5_CD ._. The_DT latter_NN was_VBD evaluated_VBN indirectly_RB
          using_VBG a_DT recombinant_JJ chimeric_JJ protein_NN containing_VBG the_DT
          extracellular_NN domain_NN of_IN the_DT BMP_NN receptor_NN type_NN IA_NNP fused_JJ to_TO
          the_DT immunoglobulin_NN Fc_NNP domain_NN (_( BMPR-IA-Fc_NNP )_) ._. The_DT chimeric_JJ
          protein_NN containing_VBG BMPR-IA_NNP was_VBD chosen_VBN because_IN it_PRP has_VBZ been_VBN
          previously_RB reported_VBN that_IN this_DT is_VBZ the_DT predominant_NN BMP_NN
          receptor_NN type_NN expressed_VBD in_IN embryonic_JJ and_CC postnatal_NN
          superior_JJ cervical_JJ ganglia_NN (_( SCG_NNP )_) [_NN 29_CD ]_NN ._. As_IN indicated_VBD in_IN
          Figure_NN 5_CD ,_, follistatin_NN and_CC noggin_NN significantly_RB inhibit_VB
          the_DT dendrite_NN promoting_VBG activity_NN of_IN BMP-_NNP 5_CD in_IN a_DT
          concentration-dependent_JJ manner_NN ._. Maximally_NNP effective_JJ
          concentrations_NNS of_IN noggin_NN (_( 1000_CD ng_NN /_NN ml_NN )_) and_CC follistatin_NN
          (_( 1000_CD ng_NN /_NN ml_NN )_) reduce_VB BMP-_NNP 5_CD -_: induced_VBN dendritic_JJ growth_NN by_IN 77_CD %_NN
          and_CC 72_CD %_NN respectively_RB ._. The_DT BMPR-IA-Fc_NNP chimera_NN also_RB
          significantly_RB inhibited_VBD BMP-_NNP 5_CD -_: induced_VBN dendritic_JJ growth_NN ._.
          Increasing_VBG the_DT concentration_NN of_IN any_DT of_IN these_DT antagonists_NNS
          to_TO levels_NNS greater_JJR than_IN those_DT expressed_VBN in_IN Figure_NN 5_CD did_VBD not_RB
          cause_VB greater_JJR inhibition_NN of_IN BMP-_NNP 5_CD -_: induced_VBN dendritic_JJ
          growth_NN (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Expression_NNP of_IN BMP-_NNP 5_CD mRNA_NN and_CC protein_NN in_IN SCG_NNP
          cells_NNS
          If_IN BMP-_NNP 5_CD is_VBZ a_DT physiological_JJ regulator_NN of_IN dendritic_JJ
          morphogenesis_NNS in_IN sympathetic_JJ neurons_NNS ,_, then_RB its_PRP$
          spatiotemporal_NN patterns_NNS of_IN expression_NN should_MD be_VB
          coincident_JJ with_IN dendritic_JJ growth_NN in_IN this_DT neuronal_NN cell_NN
          type_NN ._. Potential_JJ sources_NNS of_IN BMP-_NNP 5_CD include_VBP neuronal_NN and_CC
          glial_NN cells_NNS within_IN the_DT ganglia_NN ._. To_TO examine_VB this_DT
          possibility_NN ,_, antibody_NN (_( Ab_NNP )_) specific_JJ for_IN BMP-_NNP 5_CD was_VBD used_VBN to_TO
          immunostain_NN cocultures_NNS of_IN SCG_NNP neurons_NNS and_CC glial_NN cell_NN that_WDT
          had_VBD been_VBN cultured_JJ for_IN 2_CD weeks_NNS to_TO allow_VB for_IN significant_JJ
          expansion_NN of_IN the_DT glial_NN cell_NN population_NN ._. The_DT specificity_NN
          of_IN the_DT BMP-_NNP 5_CD Ab_NNP used_VBD in_IN these_DT experiments_NNS is_VBZ indicated_VBN by_IN
          demonstrations_NNS that_IN it_PRP recognizes_VBZ purified_JJ recombinant_JJ
          BMP-_NNP 5_CD ,_, but_CC not_RB purified_JJ recombinant_JJ BMP-_NNP 6_CD or_CC BMP-_NNP 7_CD in_IN
          Western_JJ blots_NNS (_( Figure_NN 6_CD )_) ._. Moreover_RB ,_, the_DT reaction_NN with_IN
          BMP-_NNP 5_CD protein_NN is_VBZ significantly_RB blocked_VBN by_IN preincubation_NN
          of_IN the_DT BMP-_NNP 5_CD Ab_NNP with_IN blocking_VBG peptide_NN (_( Figure_NN 6_CD )_) ._. In_IN SCG_NNP
          cultures_NNS immunostained_JJ with_IN this_DT BMP-_NNP 5_CD Ab_NNP ,_,
          immunoreactivity_NN is_VBZ present_JJ in_IN most_JJS if_IN not_RB all_DT ganglionic_JJ
          glial_NN and_CC neuronal_NN cells_NNS (_( Figure_NN 7_CD Aand_NNP 7_CD B_NNP )_) ._. In_IN glial_NN
          cells_NNS ,_, fluorescence_NN is_VBZ present_JJ throughout_IN the_DT cell_NN but_CC
          excluded_VBN from_IN the_DT nucleus_NN ;_: in_IN neurons_NNS ,_, immunoreactivity_NN
          is_VBZ evident_JJ in_IN both_DT the_DT soma_NN and_CC processes_NNS ._. Preincubation_NNP
          of_IN the_DT BMP-_NNP 5_CD Ab_NNP with_IN specific_JJ blocking_VBG peptide_NN (_( Figure_NN
          7_CD Cand_NNP 7_CD D_NNP )_) reduced_VBN BMP-_NNP 5_CD immunoreactivity_NN to_TO levels_NNS
          comparable_JJ to_TO those_DT observed_VBD in_IN control_NN cultures_NNS reacted_VBD
          with_IN the_DT secondary_JJ Ab_NNP only_RB (_( Figure_NN 7_CD Eand_NNP 7_CD F_NN )_) ._.
          BMP-_NNP 5_CD expression_NN in_IN vivo_NN was_VBD assessed_VBN by_IN RT-PCR_NNP
          analyses_NNS of_IN SCG_NNP harvested_VBN from_IN rats_NNS of_IN different_JJ ages_NNS
          corresponding_JJ to_TO various_JJ stages_NNS of_IN dendritic_JJ growth_NN in_IN
          sympathetic_JJ neurons_NNS ._. As_IN indicated_VBD in_IN Figure_NN 8_CD ,_, BMP-_NNP 5_CD mRNA_NN
          is_VBZ present_JJ in_IN SCG_NNP at_IN embryonic_JJ day_NN 20_CD (_( E_NNP 20_CD )_) ,_, which_WDT
          corresponds_NNS to_TO the_DT period_NN of_IN initial_JJ extension_NN of_IN primary_JJ
          dendrites_NNS ,_, and_CC at_IN postnatal_NN days_NNS 3_CD and_CC 7_CD (_( PN_NNP 3_CD and_CC PN_NNP 7_CD )_) ,_,
          which_WDT corresponds_NNS to_TO the_DT period_NN of_IN maximal_NN dendritic_JJ
          growth_NN ._. In_IN contrast_NN ,_, BMP-_NNP 5_CD mRNA_NN was_VBD not_RB detected_VBN in_IN adult_NN
          SCG_NNP ._.
        
      
      
        Discussion_NNP
        BMP-_NNP 5_CD is_VBZ widely_RB expressed_VBN in_IN the_DT nervous_JJ system_NN
        throughout_IN development_NN and_CC into_IN adulthood_NN [_NN 3_CD 4_CD 5_CD 6_CD ]_NN ,_, yet_RB
        the_DT only_JJ function_NN described_VBD for_IN this_DT growth_NN factor_NN thus_RB far_RB
        is_VBZ dorsal_NN patterning_VBG of_IN the_DT developing_VBG forebrain_NN [_NN 5_CD 6_CD 7_CD ]_NN
        ._. Our_PRP$ data_NNS suggest_VBP that_IN BMP-_NNP 5_CD may_MD also_RB regulate_VB later_RB
        stages_NNS of_IN neural_NN development_NN ,_, specifically_RB dendritic_JJ
        morphogenesis_NNS ._. The_DT most_RBS direct_JJ support_NN for_IN this_DT hypothesis_NNS
        is_VBZ the_DT finding_VBG that_DT addition_NN of_IN BMP-_NNP 5_CD to_TO sympathetic_JJ
        neurons_NNS in_IN culture_NN causes_NNS these_DT cells_NNS to_TO extend_VB multiple_JJ
        dendritic_JJ processes_NNS ._. These_DT data_NNS are_VBP consistent_JJ with_IN
        conclusions_NNS from_IN previous_JJ studies_NNS indicating_VBG that_IN
        dendrite-promoting_JJ activity_NN is_VBZ restricted_VBN to_TO BMPs_NNP from_IN the_DT
        60_CD A_DT or_CC dpp_NN (_( BMPs_NNP 2_CD and_CC 4_LS )_) subgroups_NNS and_CC is_VBZ not_RB observed_VBN
        with_IN BMPs_NNP from_IN other_JJ subgroups_NNS such_JJ as_IN BMP-_NNP 3_CD ,_, BMP-_NNP 13_CD or_CC
        dorsalin_NN ,_, or_CC with_IN other_JJ members_NNS of_IN the_DT TGF-Î²_NNP superfamily_RB
        such_JJ as_IN activin_NN ,_, TGF-Î²_NNP 1_CD ,_, -_: Î²_NN 2_CD or_CC -_: Î²_NN 3_CD [_NN 16_CD 17_CD ]_NN ._. Functional_NNP
        redundancy_NN between_IN BMPs_NNP of_IN the_DT 60_CD A_DT subgroup_NN has_VBZ been_VBN
        previously_RB reported_VBN with_IN respect_NN to_TO other_JJ developmental_NN
        endpoints_NNS [_NN 6_CD ]_NN ,_, of_IN which_WDT some_DT ,_, such_JJ as_IN upregulation_NN of_IN
        cell_NN adhesion_NN molecules_NNS [_NN 30_CD ]_NN ,_, may_MD be_VB directly_RB relevant_JJ
        to_TO effects_NNS on_IN dendritic_JJ growth_NN ._. BMP-_NNP 6_CD and_CC BMP-_NNP 7_CD as_RB well_RB as_IN
        dpp_NN subgroup_NN members_NNS ,_, BMP-_NNP 2_CD and_CC BMP-_NNP 4_CD ,_, have_VBP been_VBN shown_VBN to_TO
        influence_VB other_JJ aspects_NNS of_IN sympathetic_JJ neuron_NN development_NN ,_,
        such_JJ as_IN differentiation_NN of_IN adrenergic_JJ sympathetic_JJ neurons_NNS
        from_IN neural_NN crest_NN [_NN 13_CD 31_CD 32_CD 33_CD 34_CD 35_CD 36_CD 37_CD 38_CD ]_NN and_CC
        neuropeptide_NN phenotype_NN [_NN 39_CD ]_NN ._. It_PRP will_MD be_VB of_IN interest_NN to_TO
        determine_VB if_IN BMP-_NNP 5_CD also_RB exhibits_VBZ functional_JJ redundancy_NN with_IN
        respect_NN to_TO these_DT effects_NNS ._.
        Pharmacological_NNP studies_NNS of_IN BMP-_NNP 5_CD indicate_VBP that_IN relative_JJ
        to_TO BMP-_NNP 7_CD ,_, BMP-_NNP 5_CD is_VBZ less_RBR potent_JJ but_CC equally_RB efficacious_JJ in_IN
        promoting_VBG dendritic_JJ growth_NN in_IN cultured_JJ sympathetic_JJ neurons_NNS ._.
        These_DT data_NNS ,_, together_RB with_IN observations_NNS that_WDT maximally_RB
        effective_JJ concentrations_NNS of_IN BMP-_NNP 5_CD and_CC BMP-_NNP 7_CD are_VBP not_RB
        additive_JJ ,_, suggest_VBP that_IN the_DT two_CD ligands_NNS share_VBP aspects_NNS of_IN a_DT
        common_JJ signaling_VBG pathway_NN ._. It_PRP has_VBZ been_VBN shown_VBN that_DT
        phosphorylation_NN of_IN Smad-_NNP 1_CD precedes_VBZ dendritic_JJ extension_NN in_IN
        cultured_JJ sympathetic_JJ neurons_NNS exposed_VBN to_TO BMP-_NNP 7_CD ;_: moreover_RB ,_,
        expression_NN of_IN a_DT dominant_JJ negative_JJ construct_VB of_IN Smad-_NNP 1_CD in_IN
        cultured_JJ sympathetic_JJ neurons_NNS significantly_RB inhibits_NNS
        BMP-_NNP 7_CD -_: induced_VBN dendritic_JJ growth_NN in_IN these_DT neurons_NNS [_NN 23_CD ]_NN ._.
        These_DT data_NNS suggest_VBP that_DT activation_NN of_IN Smad-_NNP 1_CD is_VBZ a_DT necessary_JJ
        component_NN of_IN the_DT signal_NN transduction_NN pathway_NN by_IN which_WDT BMP-_NNP 7_CD
        induces_VBZ dendritic_JJ growth_NN ._. In_IN this_DT report_NN we_PRP demonstrate_VBP
        that_IN BMP-_NNP 5_CD similarly_RB induces_VBZ Smad-_NNP 1_CD phosphorylation_NN in_IN
        sympathetic_JJ neurons_NNS as_IN detected_VBN by_IN Western_JJ blot_NN analyses_NNS
        using_VBG antibodies_NNS specific_JJ for_IN the_DT phosphorylated_JJ form_NN of_IN
        Smad-_NNP 1_CD ._. These_DT data_NNS suggest_VBP conserved_JJ mechanisms_NNS of_IN
        signaling_VBG within_IN the_DT 60_CD A_DT subgroup_NN ._. The_DT molecular_JJ
        mechanism_NN (_( s_VBZ )_) of_IN BMP-induced_NNP dendritic_JJ growth_NN downstream_JJ of_IN
        Smad-_NNP 1_CD activation_NN are_VBP not_RB well_RB characterized_VBN ._. Previous_JJ
        studies_NNS have_VBP demonstrated_VBN that_DT transcriptional_NN and_CC
        translational_NN events_NNS are_VBP required_VBN for_IN dendritic_JJ growth_NN in_IN
        response_NN to_TO BMPs_NNP [_NN 15_CD ]_NN ,_, but_CC the_DT gene_NN expression_NN profile_NN
        responsible_JJ for_IN BMP-induced_NNP dendritic_JJ growth_NN has_VBZ yet_RB to_TO be_VB
        determined_VBN ._. Thus_RB ,_, it_PRP is_VBZ not_RB clear_JJ if_IN BMP-_NNP 5_CD or_CC -_: 7_CD induces_VBZ
        dendritic_JJ growth_NN directly_RB ,_, or_CC if_IN some_DT other_JJ factor_NN made_VBN by_IN
        the_DT cells_NNS in_IN response_NN to_TO BMPs_NNP is_VBZ responsible_JJ for_IN initiating_VBG
        dendritic_JJ growth_NN ._.
        BMPs_NNP activate_VBP Smad-_NNP 1_CD by_IN binding_JJ to_TO type_NN I_PRP and_CC type_NN II_NNP
        serine-threonine_JJ kinase_NN receptors_NNS [_NN 40_CD 41_CD ]_NN ._. Specific_JJ
        receptor_NN subunits_NNS shown_VBN to_TO bind_NN BMPs_NNP include_VBP BMP_NN receptor_NN
        type_NN IA_NNP (_( BMPR-IA_NNP )_) ,_, BMPR-IB_NNP ,_, BMR-II_NNP ,_, activin_NN receptor_NN type_NN I_PRP
        (_( ActR-I_NNP )_) ,_, and_CC ActR-II_NNP [_NN 42_CD 43_CD 44_CD ]_NN ._. BMP_NN ligands_NNS can_MD bind_NN
        to_TO either_CC type_NN I_PRP or_CC type_NN II_NNP receptor_NN subunits_NNS
        independently_RB ,_, but_CC both_DT receptor_NN types_NNS are_VBP required_VBN for_IN
        high-affinity_JJ binding_JJ and_CC signaling_VBG [_NN 40_CD ]_NN ._. The_DT finding_VBG
        that_IN the_DT soluble_JJ BMPR-IA-Fc_NNP chimera_NN significantly_RB inhibits_NNS
        BMP-_NNP 5_CD induced_VBN dendritic_JJ growth_NN suggests_VBZ that_IN BMP-_NNP 5_CD may_MD be_VB
        activating_VBG the_DT Smad-_NNP 1_CD signaling_VBG pathway_NN via_IN interactions_NNS
        with_IN BMPR-IA_NNP ._. Although_IN the_DT physiological_JJ relevance_NN of_IN this_DT
        finding_NN has_VBZ yet_RB to_TO be_VB confirmed_VBN by_IN ligand_NN binding_JJ studies_NNS
        using_VBG endogenous_JJ neuronal_NN BMPR-IA_NNP ,_, these_DT data_NNS are_VBP
        consistent_JJ with_IN reports_NNS that_IN BMPR-IA_NNP is_VBZ the_DT predominant_NN BMP_NN
        receptor_NN type_NN expressed_VBD in_IN embryonic_JJ and_CC postnatal_NN superior_JJ
        cervical_JJ ganglia_NN (_( SCG_NNP )_) [_NN 29_CD ]_NN ._.
        It_PRP is_VBZ becoming_VBG increasingly_RB evident_JJ that_DT BMP_NN signaling_VBG
        is_VBZ regulated_VBN not_RB only_RB by_IN the_DT spatiotemporal_NN expression_NN of_IN
        BMP_NN ligands_NNS and_CC receptors_NNS ,_, but_CC also_RB by_IN relative_JJ levels_NNS of_IN
        soluble_JJ BMP_NN antagonists_NNS ,_, which_WDT directly_RB bind_NN BMPs_NNP and_CC
        prevent_VB functional_JJ receptor_NN /_NN ligand_NN interaction_NN [_NN 1_CD 24_CD 25_CD 26_CD
        27_CD 28_CD ]_NN ._. The_DT different_JJ BMP_NN antagonists_NNS bind_NN to_TO BMPs_NNP and_CC
        other_JJ TGF-Î²_NNP family_NN members_NNS with_IN varying_VBG degrees_NNS of_IN
        specificity_NN ._. For_IN example_NN ,_, follistatin_NN binds_NNS both_DT activin_NN
        and_CC BMP-_NNP 7_CD avidly_RB but_CC competes_VBZ weakly_RB or_CC not_RB at_IN all_DT with_IN the_DT
        type_NN I_PRP receptor_NN for_IN BMP-_NNP 4_CD binding_JJ [_NN 25_CD 45_CD ]_NN ,_, whereas_IN
        noggin_NN binds_NNS to_TO BMPs_NNP -_: 2_CD and_CC -_: 4_CD with_IN greater_JJR affinity_NN than_IN
        BMP-_NNP 7_CD [_NN 46_CD ]_NN ._. Whether_IN BMP-_NNP 5_CD function_NN can_MD be_VB antagonized_JJ by_IN
        noggin_NN or_CC follistatin_NN has_VBZ not_RB been_VBN previously_RB reported_VBN ,_, but_CC
        our_PRP$ results_NNS suggest_VBP that_IN simultaneous_JJ addition_NN of_IN either_DT
        antagonist_NN with_IN BMP-_NNP 5_CD significantly_RB inhibits_NNS the_DT
        dendrite-promoting_JJ activity_NN of_IN BMP-_NNP 5_CD in_IN a_DT
        concentration-dependent_JJ manner_NN ._. Thus_RB ,_, profiling_VBG the_DT BMP_NN
        binding_JJ affinities_NNS as_RB well_RB as_IN the_DT expression_NN patterns_NNS of_IN
        these_DT BMP_NN antagonists_NNS will_MD be_VB critical_JJ to_TO understanding_VBG the_DT
        regulation_NN of_IN BMP-_NNP 5_CD signaling_VBG in_IN the_DT nervous_JJ system_NN ._.
        If_IN BMP-_NNP 5_CD is_VBZ important_JJ in_IN regulating_VBG dendritic_JJ growth_NN in_IN
        intact_JJ ganglia_NN ,_, its_PRP$ expression_NN should_MD correlate_VBP with_IN
        periods_NNS of_IN dendritic_JJ growth_NN 
        in_IN vivo_NN ._. In_IN sympathetic_JJ ganglia_NN ,_,
        dendritic_JJ growth_NN begins_VBZ prenatally_RB and_CC maximal_NN expansion_NN of_IN
        the_DT dendritic_JJ arbor_NN occurs_VBZ during_IN postnatal_NN weeks_NNS 1_CD and_CC 2_CD [_NN
        47_CD 48_CD ]_NN ._. RT-PCR_NNP analyses_NNS of_IN intact_JJ SCG_NNP indicate_VBP that_IN cells_NNS
        of_IN the_DT SCG_NNP express_VB BMP-_NNP 5_CD transcripts_NNS from_IN E_NNP 20_CD through_IN P_NN 7_CD ._.
        Preliminary_JJ observations_NNS indicate_VBP that_IN these_DT BMP-_NNP 5_CD
        transcripts_NNS are_VBP translated_VBN into_IN protein_NN in_IN SCG_NNP in_IN vivo_NN as_IN
        assessed_VBN by_IN Western_JJ blot_NN analyses_NNS using_VBG BMP-_NNP 5_CD Ab_NNP (_( P_NN ._. Lein_NNP ,_,
        unpublished_JJ observations_NNS )_) ._. Earlier_JJR studies_NNS have_VBP
        demonstrated_VBN the_DT expression_NN of_IN BMP-_NNP 4_CD transcripts_NNS in_IN
        developing_VBG avian_NN sympathetic_JJ ganglia_NN [_NN 49_CD ]_NN ,_, suggesting_VBG
        the_DT presence_NN of_IN multiple_JJ BMPs_NNP in_IN sympathetic_JJ ganglia_NN
        throughout_IN development_NN ._. These_DT data_NNS ,_, in_IN conjunction_NN with_IN
        observations_NNS that_WDT mRNA_NN for_IN BMP_NN type_NN IA_NNP and_CC type_NN II_NNP
        receptors_NNS are_VBP expressed_VBN in_IN the_DT developing_VBG sympathetic_JJ
        ganglia_NN [_NN 29_CD ]_NN ,_, are_VBP consistent_JJ with_IN a_DT potential_JJ role_NN for_IN
        BMP-_NNP 5_CD in_IN regulating_VBG the_DT initiation_NN and_CC rapid_JJ expansion_NN of_IN
        the_DT dendritic_JJ arbor_NN in_IN sympathetic_JJ ganglia_NN of_IN perinatal_NN
        animals_NNS ._.
        The_DT cellular_JJ distribution_NN of_IN BMP-_NNP 5_CD was_VBD determined_VBN by_IN
        immunocytochemistry_NN in_IN sympathetic_JJ neurons_NNS cocultured_JJ with_IN
        ganglionic_JJ glial_NN cells_NNS ._. Both_DT neurons_NNS and_CC glial_NN cells_NNS
        express_VBP BMP-_NNP 5_CD protein_NN ._. In_IN situ_NN hybridization_NN analyses_NNS of_IN
        BMP-_NNP 6_CD and_CC BMP-_NNP 7_CD indicate_VBP that_IN both_DT cell_NN types_NNS also_RB express_VBP
        BMP_NN transcripts_NNS (_( P_NN ._. Lein_NNP ,_, unpublished_JJ observations_NNS )_) ._. These_DT
        findings_NNS are_VBP consistent_JJ with_IN previous_JJ reports_NNS that_IN
        dendritic_JJ growth_NN can_MD be_VB induced_VBN in_IN sympathetic_JJ neurons_NNS in_IN
        vitro_NN when_WRB cultured_JJ at_IN high_JJ neuronal_NN cell_NN density_NN [_NN 50_CD ]_NN or_CC
        in_IN the_DT presence_NN of_IN ganglionic_JJ glial_NN cells_NNS [_NN 51_CD ]_NN ._.
        Dendritic_NNP growth_NN continues_VBZ ,_, albeit_IN to_TO a_DT lesser_JJR extent_NN ,_,
        into_IN adulthood_NN ,_, and_CC dendritic_JJ remodeling_NN occurs_VBZ throughout_IN
        the_DT animal_NN 's_POS life_NN ._. Mature_NNP sympathetic_JJ neurons_NNS cultured_JJ from_IN
        adult_NN animals_NNS respond_VBP to_TO BMP-_NNP 7_CD with_IN enhanced_VBN dendritic_JJ
        growth_NN [_NN 15_CD ]_NN ,_, and_CC treatment_NN with_IN BMP-_NNP 7_CD enhances_VBZ recovery_NN
        in_IN animal_NN models_NNS of_IN stroke_NN [_NN 52_CD 53_CD 54_CD 55_CD 56_CD ]_NN ._. Although_IN
        BMP-_NNP 5_CD mRNA_NN was_VBD not_RB detected_VBN in_IN adult_NN SCG_NNP ,_, Western_JJ blot_NN
        analyses_NNS indicate_VBP that_IN BMP-_NNP 5_CD protein_NN is_VBZ present_JJ in_IN adult_NN
        SCG_NNP (_( P_NN ._. Lein_NNP ,_, unpublished_JJ observations_NNS )_) ,_, presumably_RB derived_VBN
        from_IN nonganglionic_JJ sources_NNS such_JJ as_IN serum_NN or_CC target_NN tissues_NNS ._.
        These_DT observations_NNS together_RB with_IN reports_NNS that_IN BMP-_NNP 5_CD is_VBZ
        expressed_VBN at_IN significant_JJ levels_NNS in_IN the_DT adult_NN nervous_JJ system_NN
        [_NN 3_CD ]_NN suggest_VBP a_DT potential_JJ role_NN for_IN BMP-_NNP 5_CD in_IN modulating_VBG
        dendritic_JJ morphology_NN not_RB only_RB during_IN development_NN ,_, but_CC also_RB
        in_IN adult_NN nervous_JJ systems_NNS ._.
      
      
        Conclusions_NNP
        These_DT data_NNS suggest_VBP that_IN BMP-_NNP 5_CD regulates_VBZ dendritic_JJ
        growth_NN ._. Addition_NNP of_IN BMP-_NNP 5_CD to_TO sympathetic_JJ neurons_NNS in_IN culture_NN
        triggers_VBZ significant_JJ dendritic_JJ growth_NN that_WDT is_VBZ
        concentration-dependent_JJ ._. Data_NNS from_IN western_JJ blot_NN analyses_NNS
        using_VBG Ab_NNP specific_JJ for_IN phosphorylated_JJ epitopes_NNS of_IN Smad-_NNP 1_CD as_RB
        well_RB as_IN analyses_NNS of_IN dendritic_JJ growth_NN in_IN cultures_NNS exposed_VBN to_TO
        BMP-_NNP 5_CD in_IN the_DT presence_NN of_IN a_DT soluble_JJ BMPR-IA-Fc_NNP chimeric_JJ
        protein_NN are_VBP consistent_JJ with_IN a_DT signaling_VBG pathway_NN that_WDT
        involves_VBZ binding_VBG to_TO the_DT BMPR-IA_NNP and_CC activation_NN of_IN Smad-_NNP 1_CD ._.
        BMP-_NNP 5_CD signaling_VBG may_MD be_VB modulated_JJ by_IN noggin_NN and_CC follistatin_NN
        since_IN these_DT BMP_NN antagonists_NNS were_VBD observed_VBN to_TO inhibit_VB the_DT
        dendrite-promoting_JJ activity_NN of_IN BMP-_NNP 5_CD ._. Spatiotemporal_NNP
        patterns_NNS of_IN BMP-_NNP 5_CD expression_NN at_IN the_DT mRNA_NN level_NN ,_, as_IN assessed_VBN
        by_IN RT-PCR_NNP ,_, and_CC the_DT protein_NN level_NN ,_, as_IN determined_VBN by_IN
        immunocytochemistry_NN correspond_VB to_TO periods_NNS of_IN initial_JJ
        dendritic_JJ growth_NN and_CC rapid_JJ expansion_NN of_IN the_DT dendritic_JJ
        arbor_NN ._. These_DT observations_NNS ,_, together_RB with_IN previously_RB
        published_VBN reports_NNS from_IN other_JJ laboratories_NNS indicating_VBG
        significant_JJ levels_NNS of_IN BMP-_NNP 5_CD expression_NN in_IN the_DT developing_VBG
        and_CC adult_NN nervous_JJ system_NN [_NN 3_CD ]_NN suggest_VBP a_DT potential_JJ role_NN for_IN
        BMP-_NNP 5_CD in_IN modulating_VBG dendritic_JJ morphology_NN not_RB only_RB during_IN
        development_NN ,_, but_CC also_RB in_IN adult_NN nervous_JJ systems_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Materials_NNS
          Purified_NNP human_JJ recombinant_JJ BMPs_NNP (_( 5_CD ,_, 6_CD and_CC 7_CD )_) were_VBD
          prepared_VBN using_VBG previously_RB published_VBN methods_NNS [_NN 57_CD ]_NN and_CC
          provided_VBN by_IN Creative_NNP Biomolecules_NNP (_( Hopkinton_NNP ,_, MA_NNP )_) ._.
          Affinity-purified_NNP polyclonal_NN antibody_NN (_( Ab_NNP )_) specific_JJ for_IN
          BMP-_NNP 5_CD ,_, the_DT blocking_VBG peptide_NN for_IN the_DT BMP-_NNP 5_CD Ab_NNP ,_, and_CC the_DT
          recombinant_JJ human_JJ BMP-RIA-Fc_NNP chimera_NN were_VBD purchased_VBN from_IN
          Research_NNP Diagnostics_NNPS (_( Flanders_NNP ,_, NJ_NNP )_) ._. Ab_NNP specific_JJ for_IN the_DT
          phosphorylated_JJ form_NN of_IN Smad-_NNP 1_CD (_( Ser_NNP 463_CD /_NN 465_CD )_) as_RB well_RB as_IN Ab_NNP
          that_WDT recognizes_VBZ both_DT phosphorylated_JJ and_CC nonphosphorylated_JJ
          Smad-_NNP 1_CD (_( e_SYM ._. g_SYM ._. ,_, total_JJ Smad-_NNP 1_LS )_) was_VBD purchased_VBN from_IN Upstate_NNP
          Biological_NNP (_( Lake_NNP Placid_NNP ,_, NY_NNP )_) ._. 
          Xenopus_NNP noggin_NN protein_NN [_NN 58_CD ]_NN was_VBD
          the_DT generous_JJ gift_NN of_IN Drs_NNP ._. JosÃ¨_NNP de_IN JesÃºs_NNP and_CC Richard_NNP
          Harland_NNP (_( UC_NNP at_IN Berkeley_NNP )_) ._. Recombinant_NNP human_JJ follistatin_NN
          (_( B_NNP 4384_CD )_) was_VBD obtained_VBN through_IN Dr_NNP ._. A_DT ._. F_NN ._. Parlow_NNP at_IN the_DT NHPP_NNP ,_,
          NIDDK_NNP (_( Torrance_NNP ,_, CA_NNP )_) ._.
        
        
          Tissue_NNP culture_NN
          Sympathetic_NNP neurons_NNS were_VBD dissociated_JJ from_IN the_DT SCG_NNP of_IN
          perinatal_NN (_( E_NNP 21_CD to_TO PN_NNP 1_LS )_) Holtzmann_NNP rats_NNS (_( Harlan_NNP
          Sprague-_NNP Dawley_NNP ,_, Rockford_NNP ,_, IL_NNP )_) according_VBG to_TO previously_RB
          described_VBD methods_NNS [_NN 59_CD ]_NN ._. Cells_NNP were_VBD plated_JJ onto_IN glass_NN
          coverslips_NNS (_( for_IN immunocytochemical_JJ and_CC morphological_JJ
          studies_NNS )_) or_CC 35_CD mm_NN plastic_NN culture_NN dishes_NNS (_( for_IN Western_JJ
          blot_NN analyses_NNS )_) precoated_JJ with_IN 100_CD Î¼g_NN /_NN ml_NN poly-_NN D-_NNP lysine_NN
          (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. Cultures_NNP were_VBD maintained_VBN in_IN
          serum-free_JJ medium_NN supplemented_JJ with_IN Î²-_NN NGF_NNP (_( 100_CD ng_NN /_NN ml_NN )_) ,_,
          bovine_JJ serum_NN albumin_NN (_( 500_CD Î¼g_NN /_NN ml_NN )_) ,_, insulin_NN (_( 10_CD Î¼g_NN /_NN ml_NN )_) ,_, and_CC
          transferrin_NN (_( 20_CD Î¼g_NN /_NN ml_NN )_) ._. In_IN most_JJS experiments_NNS ,_, endogenous_JJ
          non-neuronal_JJ cells_NNS were_VBD eliminated_VBN from_IN cultures_NNS by_IN
          adding_VBG cytosine-Î²-_JJ D-_NNP arabinofuranoside_NN (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_,
          MO_NNP )_) to_TO the_DT culture_NN medium_NN at_IN 1_CD Î¼M_NN for_IN 48_CD hr_NN beginning_VBG on_IN
          day_NN 2_CD ._. In_IN some_DT experiments_NNS this_DT antimitotic_JJ was_VBD not_RB added_VBN
          to_TO cultures_NNS but_CC rather_RB endogenous_JJ non-neuronal_JJ cells_NNS were_VBD
          allowed_VBN to_TO proliferate_VBP ._. Previous_JJ studies_NNS have_VBP
          demonstrated_VBN that_IN under_IN these_DT culture_NN conditions_NNS ,_, the_DT
          non-neuronal_JJ cells_NNS are_VBP primarily_RB ganglionic_JJ glia_NN [_NN 51_CD ]_NN
          ._.
        
        
          Morphological_NNP analyses_NNS
          Dendritic_NNP growth_NN was_VBD assessed_VBN in_IN cultures_NNS
          immunostained_JJ with_IN monoclonal_NN antibodies_NNS (_( mAb_NN )_) previously_RB
          shown_VBN to_TO react_VB selectively_RB with_IN the_DT somatodendritic_JJ
          compartment_NN of_IN cultured_JJ sympathetic_JJ neurons_NNS [_NN 16_CD ]_NN ._.
          These_DT mAb_NN 's_POS include_VBP SMI-_NNP 52_CD ,_, which_WDT is_VBZ specific_JJ for_IN the_DT
          cytoskeletal_NN protein_NN MAP_NNP 2_CD ,_, and_CC SMI-_NNP 32_CD ,_, which_WDT reacts_VBZ with_IN
          the_DT non-phosphorylated_JJ forms_NNS of_IN the_DT M_NNP and_CC H_NNP neurofilament_NN
          subunits_NNS (_( Sternberger_NNP Immunocytochemicals_NNP ,_, Baltimore_NNP ,_,
          MD_NNP )_) ._. Antigens_NNP were_VBD localized_VBN by_IN indirect_JJ
          immunofluorescence_NN as_RB previously_RB described_VBD [_NN 16_CD ]_NN ._.
          Dendritic_NNP growth_NN was_VBD quantified_VBN using_VBG SPOT_NNP image_NN analysis_NN
          system_NN ._. Data_NNS in_IN the_DT text_NN are_VBP presented_VBN as_IN the_DT mean_JJ Â±_NN
          S_NNP ._. E_NNP ._. M_NNP ._. and_CC statistical_JJ significance_NN was_VBD determined_VBN using_VBG
          ANOVA_NNP followed_VBN by_IN Tukey_NNP 's_POS test_NN ._.
        
        
          Western_JJ blot_NN analyses_NNS
          Western_JJ blot_NN analyses_NNS were_VBD performed_VBN on_IN purified_JJ
          recombinant_JJ BMPs_NNP to_TO assess_VB the_DT specificity_NN of_IN the_DT BMP-_NNP 5_CD
          Ab_NNP ,_, and_CC on_IN cell_NN lysates_NNS of_IN cultured_JJ sympathetic_JJ neurons_NNS
          to_TO assess_VB the_DT effects_NNS of_IN BMP-_NNP 5_CD on_IN phosphorylation_NN of_IN
          Smad_NNP 1_CD as_RB well_RB as_IN levels_NNS of_IN total_JJ Smad_NNP (_( nonphosphorylated_JJ
          and_CC phosphorylated_JJ )_) ._. Cell_NNP lysates_NNS were_VBD obtained_VBN by_IN
          rinsing_VBG 12_CD -_: day_NN old_JJ neuronal_NN cell_NN cultures_NNS with_IN ice-cold_JJ
          phosphate-buffered_JJ saline_NN prior_RB to_TO trituration_NN in_IN
          ice-cold_JJ lysis_NNS buffer_NN (_( PBS_NNP supplemented_JJ with_IN 1_CD %_NN Igepal_NNP ,_,
          0_CD ._. 5_CD %_NN sodium_NN deoxycholate_NN ,_, 0_CD ._. 1_CD %_NN SDS_NNP ,_, 100_CD Î¼g_NN /_NN ml_NN PMSF_NNP and_CC
          300_CD Î¼g_NN /_NN ml_NN aprotinin_NN )_) ._. Cell_NNP lysates_NNS were_VBD microfuged_JJ at_IN
          maximum_NN speed_NN for_IN 5_CD min_NN and_CC the_DT resultant_JJ supernatant_NN
          collected_VBN ._. Protein_NNP concentration_NN was_VBD determined_VBN using_VBG the_DT
          Bradford_NNP assay_NN (_( BioRad_NNP ,_, Hercules_NNP ,_, CA_NNP )_) ._. Samples_NNP containing_VBG
          equivalent_NN amounts_NNS of_IN protein_NN were_VBD resolved_VBN by_IN 12_CD %_NN
          polyacrylamide_NN SDS_NNP PAGE_NNP under_IN reducing_VBG conditions_NNS and_CC
          then_RB electroblotted_JJ onto_IN PVDF_NNP membranes_NNS ._. Blots_NNP were_VBD
          blocked_VBN at_IN room_NN temperature_NN for_IN 1_CD hour_NN in_IN TBS-T_NNP (_( 10_CD mM_NN
          Tris_NNP ,_, pH_NN 8_CD ._. 0_CD ,_, 150_CD mM_NN NaCl_NNP ,_, 0_CD ._. 1_CD %_NN Tween-_NNP 20_CD )_) containing_VBG 5_CD %_NN
          dried_VBD fat-free_JJ milk_NN ,_, then_RB incubated_JJ overnight_JJ at_IN 4_CD Â°_NN C_NNP in_IN
          TBS-T_NNP containing_VBG 0_CD ._. 5_CD %_NN milk_NN and_CC primary_JJ Ab_NNP (_( 0_CD ._. 5_LS Î¼g_NN /_NN ml_NN for_IN
          BMP-_NNP 5_CD Ab_NNP ;_: 10_CD Î¼g_NN /_NN ml_NN for_IN Smad-_NNP 1_CD Ab_NNP )_) ._. Blots_NNP were_VBD washed_VBN
          twice_RB with_IN TBS-T_NNP containing_VBG 0_CD ._. 5_CD %_NN milk_NN ,_, then_RB incubated_JJ at_IN
          room_NN temperature_NN for_IN 2_CD hours_NNS in_IN TBS-T_NNP containing_VBG 0_CD ._. 5_CD %_NN
          milk_NN and_CC 1_CD :_: 5000_CD dilutions_NNS of_IN secondary_JJ Ab_NNP conjugated_JJ to_TO
          peroxidase_NN (_( for_IN BMP-_NNP 5_CD ,_, anti-goat_JJ IgG-peroxidase_NNP from_IN
          Chemicon_NNP ,_, Temecula_NNP CA_NNP ;_: for_IN Smad_NNP 1_CD ,_, anti-rabbit_JJ
          Ig-peroxidase_NNP from_IN Amersham_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_) ._.
          Subsequently_RB ,_, blots_NNS were_VBD washed_VBN three_CD times_NNS as_IN described_VBN
          above_IN ,_, and_CC visualized_JJ using_VBG an_DT enhanced_JJ chemiluminescence_NN
          detection_NN method_NN (_( ECL_NNP ,_, Amersham_NNP )_) ._. Blots_NNP of_IN cell_NN lysates_NNS
          were_VBD stripped_VBN and_CC reprobed_JJ using_VBG antibodies_NNS specific_JJ for_IN
          Î±-tubulin_JJ (_( 1_CD :_: 10_CD ,_, 000_CD ,_, Sigma_NNP )_) ._. To_TO quantify_VB data_NNS ,_, films_NNS were_VBD
          scanned_JJ using_VBG an_DT HP_NNP ScanJet_NNP ADF_NNP scanner_NN and_CC HP_NNP Precision_NNP
          ScanPro_NNP software_NN ,_, and_CC band_NN density_NN determined_VBN as_IN
          arbitrary_JJ absorption_NN units_NNS using_VBG the_DT MacBas_NNP software_NN
          program_NN (_( version_NN 2_CD ._. 31_CD ,_, Fuji_NNP Film_NNP )_) ._.
        
        
          Immunocytochemistry_NNP
          BMP-_NNP 5_CD Ab_NNP was_VBD used_VBN to_TO localize_NN BMP-_NNP 5_CD protein_NN in_IN SCG_NNP
          cultures_NNS containing_VBG sympathetic_JJ neurons_NNS and_CC ganglionic_JJ
          glial_NN cells_NNS ._. After_IN 2_CD weeks_NNS in_IN culture_NN ,_, cells_NNS were_VBD fixed_VBN
          in_IN 4_CD %_NN paraformaldehyde_NN ,_, permeabilized_JJ with_IN methanol_NN at_IN
          -_: 20_CD Â°_NN C_NNP (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) ,_, and_CC then_RB reacted_VBD with_IN
          anti-_NN BMP-_NNP 5_CD Ab_NNP (_( 10_CD Î¼g_NN /_NN ml_NN )_) ._. Immunoreactivity_NNP was_VBD visualized_JJ
          by_IN indirect_JJ immunofluorescence_NN as_RB previously_RB described_VBD [_NN
          16_CD ]_NN ._. The_DT specificity_NN of_IN the_DT immunoreaction_NN was_VBD
          determined_VBN by_IN preincubating_VBG the_DT BMP-_NNP 5_CD Ab_NNP with_IN its_PRP$
          specific_JJ blocking_VBG peptide_NN (_( 100_CD Î¼g_NN /_NN ml_NN )_) prior_RB to_TO reaction_NN
          with_IN the_DT cultures_NNS ._.
        
        
          RNA_NNP Isolation_NNP and_CC Analyses_NNS
          Total_NNP RNA_NNP was_VBD extracted_VBN from_IN freshly_RB harvested_VBN
          superior_JJ cervical_JJ ganglia_NN (_( SCG_NNP )_) using_VBG Trizol_NNP (_( Life_NNP
          Technology_NNP ,_, Carlsbad_NNP ,_, CA_NNP )_) ._. RNA_NNP samples_NNS (_( 5_CD Î¼g_NN )_) were_VBD
          reverse_VB transcribed_JJ using_VBG random_JJ primers_NNS at_IN annealing_VBG
          temperatures_NNS of_IN 65_CD Â°_NN C_NNP (_( You-_NNP Prime-the-_NNP First-_NNP Strand_NNP kit_NN ,_,
          Amersham_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_) ._. Resultant_NNP cDNA_NN was_VBD amplified_VBN
          by_IN PCR_NNP for_IN 35_CD cycles_NNS using_VBG an_DT annealing_VBG temperature_NN of_IN
          55_CD Â°_NN C_NNP for_IN 30_CD sec_NN and_CC denaturing_VBG temperature_NN of_IN 95_CD Â°_NN C_NNP for_IN 30_CD
          sec_NN ;_: the_DT Mg_NNP +_NN +_NN concentration_NN in_IN these_DT reactions_NNS was_VBD 1_CD ._. 5_CD
          mM_NN ._. As_IN a_DT negative_JJ control_NN ,_, each_DT sample_NN was_VBD run_VBN through_IN
          PCR_NNP without_IN prior_JJ reverse-transcription_JJ ._. Primers_NNP used_VBD for_IN
          amplification_NN of_IN BMP-_NNP 5_CD cDNA_NN were_VBD designed_VBN to_TO unique_JJ
          sequences_NNS of_IN rat_NN BMP-_NNP 5_CD using_VBG the_DT Primer_NNP 3_CD program_NN
          http_NN :_: /_NN /_NN www-genome_JJ ._. wi_NN ._. mit_NN ._. edu_NN /_NN cgi-bin_JJ /_NN primer_NN /_NN primer_NN 3_CD __NN www_NN ._. cgi_NN ._.
          The_DT specific_JJ primer_NN sequences_NNS were_VBD BMP-_NNP 5_CD sense_NN ,_,
          5_CD '_POS -_: TTATGCAAAAGGAGGCTTGG-_NNP 3_CD '_POS and_CC BMP-_NNP 5_CD antisense_NN ,_,
          5_CD '_POS -_: TCATGACCATGTCAGCATCA-_NNP 3_CD '_'' ._. After_IN synthesis_NN ,_, PCR_NNP products_NNS
          were_VBD subjected_VBN to_TO 1_CD %_NN agarose_NN gel_NN electrophoresis_NNS and_CC
          found_VBD to_TO have_VB the_DT expected_VBN size_NN of_IN 420_CD base_NN pairs_NNS ._.
        
      
      
        List_NN of_IN abbreviations_NNS
        Ab_NNP ,_, polyclonal_NN antibody_NN
        BMP_NN ,_, bone_NN morphogenetic_JJ protein_NN
        BMPR-IA_NNP ,_, BMP_NN receptor_NN type_NN IA_NNP
        E_NNP 20_CD or_CC E_NNP 21_CD ,_, embryonic_JJ day_NN 20_CD or_CC 21_CD
        mAb_NN ,_, monoclonal_NN antibody_NN
        PN_NNP 1_CD ,_, PN_NNP 3_CD or_CC PN_NNP 7_CD ,_, postnatal_NN day_NN 1_CD ,_, 3_CD or_CC 7_CD
        SCG_NNP ,_, superior_JJ cervical_JJ ganglia_NN
      
    
  
